DLL4 and uveitis: Additionally, our previous dual luciferase report gene expression assay showed that rno-miR-30b-5p specifically target Notch1 and DLL4 [54], so miR-30b-5p could serve as a promising immunoregulatory approach for the treatment of uveitis.